29 Jan 2025 | Shareholder Report

Skip to main content

Shareholder Report

Shareholder Report
📁 Objectives
📁 Team
📁 Sales
📁 Financials
Board Meetings
Trajectory & Recognition
Cap Table
📝 Shareholder agreement

Board Meetings
29 Jan 2025

Board Meeting

29 January 2025

Agenda

Review

2024 year-end review
Financial and commercial performance, comparison with forecasted objectives
2025 business plan
Annual strategic objectives, financial and commercial projections
Approval for change in the deeds
Modification of the company's corporate CNAE
Structure and team
Identification of talent needs, retention and professional development strategies

Discussion

CEO variable compensation
Evaluation based on 2024 results; definition of 2025 criteria
Challenges and opportunities
Definition of variable compensation for the sales team; client issue (Teladoc)
Open floor

Agenda

All the information contained in this data room is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)